New Orleans BioFund
19
1M
9
2.11
0.53
- Areas of investment
Summary
New Orleans BioFund is the famous VC, which was founded in 2013. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New Orleans.
Deals in the range of 100 thousands - 1 million dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2017.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the New Orleans BioFund, startups are often financed by Small Business Innovation Research, New World Angels, National Science Foundation. The meaningful sponsors for the fund in investment in the same round are SOSV, Mount Wilson Ventures, Lagniappe Angels. In the next rounds fund is usually obtained by SOSV, National Institutes of Health, IndieBio.
The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Chemical, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Microbiome Therapeutics, Bioceptive, AxoSim. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 0
- Rounds per year
- 2.11
- Follow on index
- 0.53
- Investments by industry
- Biotechnology (13)
- Life Science (10)
- Health Care (8)
- Biopharma (6)
- Manufacturing (5) Show 13 more
- Investments by region
-
- United States (19)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.42
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AxoSim | 01 Jun 2019 | Biotechnology, Medical, Life Science, Neuroscience, Pharmaceutical, Biopharma | Seed | United States, Louisiana, New Orleans | |
| Obatala Sciences | 28 Apr 2022 | Biotechnology, Life Science | Early Stage Venture | United States, Louisiana, New Orleans |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.